Neonatal Fc receptor mAb (lowers Igs) development:
2021 FDA approved efgartigimod (Vyvgart) for myasthenia gravis
2023 FDA approved rozanolixizumab (Rystiggo) for MG
2023 nipocalimab promising efficacy in RA, Sjogrens, hemolytic anemia, MG
INTERESTING? https://t.co/Ou9An9EvUK https://t.co/XDDELNAYYD
Links:
Johnson & Johnson reports positive topline results for nipocalimab from a Phase…
https://prn.to/3Ig8HSl
Feb-28-2024
